SynthesisTherapeutic advances in respiratory disease

Omalizumab and long-term quality of life outcomes in patients with moderate-to-severe allergic asthma: a systematic review.

Giorgio Lorenzo Colombo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.